We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$819M
AUM Growth
+$28.3M
Cap. Flow
+$39.9M
Cap. Flow %
4.88%
Top 10 Hldgs %
73.47%
Holding
2,597
New
508
Increased
1,194
Reduced
436
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 5.03%
2 Healthcare 3.05%
3 Consumer Staples 2.87%
4 Financials 2.11%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
2176
Fate Therapeutics
FATE
$319M
$78 ﹤0.01%
+65
New +$79
INOD icon
2177
Innodata
INOD
$2.05B
$78 ﹤0.01%
+2
New +$100
NWPX icon
2178
NWPX Infrastructure Inc
NWPX
$1.08B
$78 ﹤0.01%
+1
New +$72
AMBP icon
2179
Ardagh Metal Packaging
AMBP
$3.02B
$77 ﹤0.01%
19
+5
+36% +$22
IBRX icon
2180
ImmunityBio
IBRX
$8.05B
$77 ﹤0.01%
10
-54
-84% -$370
BRSL
2181
Brightstar Lottery PLC
BRSL
$2.07B
$77 ﹤0.01%
+6
New +$83
PRGS icon
2182
Progress Software
PRGS
$1.77B
$77 ﹤0.01%
3
FG icon
2183
F&G Annuities & Life
FG
$3.51B
$76 ﹤0.01%
3
-45
-94% -$1.17K
NGS icon
2184
Natural Gas Services Group
NGS
$474M
$76 ﹤0.01%
+2
New +$73
PLUS icon
2185
ePlus
PLUS
$2.32B
$76 ﹤0.01%
1
BBBY
2186
Bed Bath & Beyond
BBBY
$407M
$75 ﹤0.01%
+16
New +$90
AIRS icon
2187
AirSculpt Technologies
AIRS
$232M
$74 ﹤0.01%
+26
New +$61
CDZI icon
2188
Cadiz
CDZI
$299M
$74 ﹤0.01%
+15
New +$82
TASK icon
2189
TaskUs
TASK
$633M
$74 ﹤0.01%
+11
New +$116
BEAM icon
2190
Beam Therapeutics
BEAM
$2.77B
$72 ﹤0.01%
3
MYGN icon
2191
Myriad Genetics
MYGN
$308M
$72 ﹤0.01%
16
-39
-71% -$203
CNMD icon
2192
CONMED
CNMD
$1.48B
$71 ﹤0.01%
+2
New +$81
FA icon
2193
First Advantage
FA
$3.64B
$71 ﹤0.01%
+6
New +$73
SRCE icon
2194
1st Source
SRCE
$2.12B
$70 ﹤0.01%
1
EFSI
2195
Eagle Financial Services Inc
EFSI
$233M
$70 ﹤0.01%
2
THRY icon
2196
Thryv Holdings
THRY
$95.1M
$69 ﹤0.01%
+25
New +$98
VVX icon
2197
V2X
VVX
$2.52B
$69 ﹤0.01%
1
AMSC icon
2198
American Superconductor
AMSC
$1.56B
$68 ﹤0.01%
2
-3
-60% -$95
RGP icon
2199
Resources Connection
RGP
$144M
$68 ﹤0.01%
+18
New +$74
LION icon
2200
Lionsgate Studios
LION
$3.53B
$68 ﹤0.01%
7
+1
+17% +$9

Similar funds

SJS Investment Consulting's Q1 2026 Portfolio in Review

As of Q1 2026, SJS Investment Consulting held 2,597 positions worth $819M, up 3.6% from $790M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

SJS Investment Consulting deployed $39.9M of net new capital in Q1 2026, opening 508 new positions and adding to 1,194 existing holdings. Its largest new stake was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Apple, an estimated $1.32M trimmed.

  • SJS Investment Consulting's largest Q1 2026 buy was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q1 2026, an estimated $4.83M increase.
  • SJS Investment Consulting's biggest Q1 2026 reduction was Apple, cutting an estimated $1.32M.
  • SJS Investment Consulting fully exited GeneDx Holdings in Q1 2026, selling an estimated $390K.
  • SJS Investment Consulting's ten largest holdings make up 73% of its $819M portfolio in Q1 2026.
  • SJS Investment Consulting opened 508 new positions and closed 123 in Q1 2026.
  • SJS Investment Consulting's portfolio value rose 3.6% quarter-over-quarter to $819M.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.